AMEND news in Tag: Genetic Neuroendocrine Tumour Syndromes

• AMEND Represents GenNETS Internationally

  

  From 7-8 September, AMEND CEO, Jo Grey, represented our Genetic Neuroendocrine Tumour Syndrome (GenNETS) patient communities at the annual summit of the International Neuroendocrine Cancer Alliance in Sofia, Bulgaria.

  Click here for more information

• Special Event for Scottish Members

  

  Come and join Peer Support Volunteer for Scotland, Amanda Shaw, with special guest, Genetic Counsellor, Nicola Bradshaw, on Saturday 14th September for networking, peers support and information at this in-person event near Glasgow.

  Click here for more information and to book

• Archived news
• 2026
• 2025
• 2024
• 2023
• 2022
• 2021
• 2020
• 2019
• 2018
• 2017
• 2016